- The paper presents RA-GCN, a novel adversarial graph convolutional network that dynamically re-weights samples to counter class imbalance in disease prediction.
- It integrates separate weighting networks with a GCN classifier to optimize weighted cross-entropy loss and enhance accuracy on minority classes.
- Extensive validation on medical datasets shows RA-GCN outperforms traditional approaches with improved accuracy, macro F1-score, and ROC AUC metrics.
RA-GCN: Graph Convolutional Network for Disease Prediction Problems with Imbalanced Data
The paper presents a novel method, the Re-weighted Adversarial Graph Convolutional Network (RA-GCN), designed to address the challenge of class imbalance in disease prediction using Graph Convolutional Networks (GCNs). The method particularly focuses on enhancing the predictive performance of GCNs in medical datasets characterized by class imbalance, where the number of samples in different classes is significantly disproportionate. Such imbalance often leads to models that favor the majority class, thereby reducing the accuracy in identifying minority classes, which are frequently the cases of interest in medical applications.
Methodology
RA-GCN innovatively combines GCNs with adversarial training, employing separate graph-based neural networks for each class to dynamically assign weights to samples during the training process. This adaptive weighting mechanism prevents the classifier from overemphasizing samples from any particular class, which is a common issue when class imbalance is present. The proposed model incorporates two main components: a GCN-based classifier responsible for node classification, and a series of weighting networks, each focusing on learning the appropriate sample weights for one class.
The adversarial nature of the training process involves the classifier minimizing the weighted cross-entropy loss, while the weighting networks are designed to maximize the importance of the samples that are more challenging for the classifier. This adversarial setup enables the system to learn a balanced classification boundary, addressing biases introduced by class imbalance.
Experimental Validation and Results
The authors validate RA-GCN on both synthetic data and real-world medical datasets, including the Pima Indian Diabetes dataset, Parkinson's Progression Markers Initiative dataset, and the Haberman's survival dataset. Across these datasets, RA-GCN consistently demonstrates superior performance compared to both weighted and unweighted versions of traditional GCNs and Multi-Layer Perceptrons (MLPs), as well as a state-of-the-art method for handling class imbalance in GCNs, referred to as DR-GCN.
The results are measured in terms of accuracy, macro F1-score, and ROC AUC, which collectively offer a comprehensive evaluation of the classifier's performance across both majority and minority classes. RA-GCN achieves higher metrics by effectively discriminating between poorly represented classes while maintaining high overall accuracy. This success is attributed to its capability to balance the classes during training dynamically.
Implications and Future Directions
The development of RA-GCN has significant implications for machine learning applications in healthcare, particularly in tasks involving critical but low-prevalence conditions where it is essential to minimize false negatives. Beyond healthcare, RA-GCN's adversarial sample weighting strategy could be adapted to other domains suffering from class imbalance, such as fraud detection and anomaly detection.
Future research could explore the extension of RA-GCN to multi-label classification scenarios, seek methods to integrate this approach with other GCN architectures and implement further optimization for training on very large graphs. Furthermore, the inductive learning capabilities, which allow for predictions on unseen nodes, could be a valuable avenue, given the transductive nature of the current model setting. These directions promise to enhance the utility and robustness of GCNs in various imbalanced-class scenarios.